fosaprepitant dimeglumine

Sandoz Inc🇺🇸 United States

FDA Page

Effective Date: Dec 1, 2019
Approval ID: e8055dfe-f5cd-4784-84e6-2d105b0d4c91
Products: 1 registered
Version: 12

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively.See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous useInitial U.S. Approval: 2008

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.